RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
-11.86%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.23B
AUM Growth
+$1.23B
(-10%)
Cap. Flow
+$59M
Cap. Flow
% of AUM
4.8%
Top 10 Holdings %
Top 10 Hldgs %
29.04%
Holding
133
New
16
Increased
54
Reduced
20
Closed
13
Top Buys
| 1 |
STJ
St Jude Medical
STJ
|
$33.4M |
| 2 |
AET
Aetna Inc
AET
|
$25.1M |
| 3 |
Acadia Healthcare
ACHC
|
$19.9M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$18.4M |
| 5 |
CHMA
Chiasma, Inc. Common Stock
CHMA
|
$10.4M |
Top Sells
| 1 |
Medtronic
MDT
|
$42.2M |
| 2 |
THOR
THORATEC CORPORATION
THOR
|
$26.1M |
| 3 |
Humana
HUM
|
$25.2M |
| 4 |
McKesson
MCK
|
$14.7M |
| 5 |
Bausch Health
BHC
|
$13.7M |
Sector Composition
| 1 | Healthcare | 76.16% |
| 2 | Financials | 3.43% |
| 3 | Technology | 0.48% |
| 4 | Industrials | 0.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Travere Therapeutics
TVTX
$1.75B
| $13.9M | 1.12% |
683,900
+8,900
| +1% | +$180K |
|
|
TRNX
27
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $13.5M | 1.09% |
660,000
| – | – |
|
|
28
McKesson
MCK
$85.9B
| $13M | 1.05% |
70,000
-79,500
| -53% | -$14.7M |
|
29
Encompass Health
EHC
$12.5B
| $13M | 1.05% |
337,500
+80,000
| +31% | +$3.07M |
|
30
Incyte
INCY
$17B
| $12.5M | 1.01% |
113,000
| – | – |
|
31
Elevance Health
ELV
$72.4B
| $12.3M | 0.99% |
87,500
+36,000
| +70% | +$5.04M |
|
32
Thermo Fisher Scientific
TMO
$183B
| $12.2M | 0.99% |
100,000
| – | – |
|
33
Ardelyx
ARDX
$1.57B
| $11.8M | 0.96% |
681,500
+71,500
| +12% | +$1.24M |
|
34
CVS Health
CVS
$93B
| $11.6M | 0.94% |
120,000
-44,000
| -27% | -$4.25M |
|
35
Amgen
AMGN
$153B
| $11.5M | 0.93% |
83,250
-72,750
| -47% | -$10.1M |
|
36
Biogen
BIIB
$20.8B
| $11.3M | 0.92% |
38,650
| – | – |
|
37
Prothena Corp
PRTA
$452M
| $11.2M | 0.91% |
248,000
-2,000
| -0.8% | -$90.7K |
|
|
SRGA
38
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $10.6M | 0.86% |
1,860,000
| – | – |
|
|
CHMA
39
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $10.4M | 0.84% |
+522,500
| New | +$10.4M |
|
40
Ultragenyx Pharmaceutical
RARE
$3.04B
| $10.3M | 0.84% |
107,000
+15,000
| +16% | +$1.44M |
|
|
ZSPH
41
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $10.2M | 0.83% |
155,000
-4,000
| -3% | -$263K |
|
|
ANAC
42
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $10.1M | 0.82% |
+86,000
| New | +$10.1M |
|
|
CORV
43
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $10M | 0.82% |
1,190,000
+565,000
| +90% | +$4.77M |
|
|
PRAH
44
DELISTED
PRA Health Sciences, Inc.
PRAH
| $9.82M | 0.8% |
253,000
-32,000
| -11% | -$1.24M |
|
45
Pediatrix Medical
MD
$1.45B
| $9.6M | 0.78% |
+125,000
| New | +$9.6M |
|
46
Cooper Companies
COO
$13.3B
| $9.21M | 0.75% |
61,900
+7,900
| +15% | +$1.18M |
|
|
TSRO
47
DELISTED
TESARO, Inc.
TSRO
| $9.06M | 0.74% |
226,000
+9,000
| +4% | +$361K |
|
|
ADAP
48
Adaptimmune Therapeutics
ADAP
$13.9M
| $9.05M | 0.73% |
756,100
-148,900
| -16% | -$1.78M |
|
49
DaVita
DVA
$9.72B
| $8.83M | 0.72% |
122,050
| – | – |
|
|
INSY
50
DELISTED
Insys Therapeutics, Inc.
INSY
| $8.77M | 0.71% |
308,000
+161,000
| +110% | +$4.58M |
|